Dr Jill Jarecki Discusses Whether Gender Affects SMA Severity

October 31st 2020, 11:00am


Jill Jarecki, PhD, chief scientific officer at Cure SMA explained the current data and potential for gender to impact the severity spinal muscular atrophy (SMA).

New Recommendations Open Door a Bit to Stem Cell Transplant for MS

October 31st 2020, 10:00am


The procedure might work best in patients who have had multiple sclerosis (MS) for less than 10 years, the report said.

Review of Ketamine in ED for Acute Pain Finds Similar Efficacy to Other Pain Relief

October 30th 2020, 11:30pm


The study compared patients given-low-dose ketamine with those given morphine for acute pain relief.

Broad Testing for Multiple Genes Benefits Patients With Cancer, Relatives

October 30th 2020, 9:45pm


Researchers conducting broad next-generation sequencing discovered more actionable variants in patients and families than they would have otherwise; they did so by using a universal approach, rather than sticking with clinical guidelines.

Dr John Corboy on Probing Patient Quality of Life Off Medication for MS

October 30th 2020, 2:00pm


Quality of life for patients with multiple sclerosis (MS) could be better when they are off medication because they will not have adverse effects related to those medications, said John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine.

Dr Nicola Hanania Examines COPD Clinical Uncertainties

October 30th 2020, 12:00pm


Major issues still surround COPD treatment, noted Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.

Foundation Medicine Notches Additional FDA Approvals

October 29th 2020, 11:30pm


The FDA has approved new indications for Foundation Medicine's liquid biopsy assay and also its tissue-based companion diagnostic for solid tumors.

Use of Triplet Therapy Rose in R/R MM as Deaths Declined, Study Finds

October 29th 2020, 9:45pm


Newer therapies have led to a boost in the number of patients with relapsed or refractory multiple myeloma (R/R MM) who are prescribed triplet regimens. As that shift has occurred, death rates appear to have dropped.

Prior Malignancy Linked to Risk of Secondary Malignancy in Follicular Lymphoma

October 29th 2020, 4:00am


Previous research has found a link between a prior malignancy and secondary primary malignancy risk in patients with multiple myeloma. A new study suggests a similar association in follicular lymphoma.

Weighing the Pros, Cons of At-Home Use of Biologics for Asthma

October 28th 2020, 7:30pm


When the first biologic to treat asthma was approved by the FDA in 2003, it needed to be administered subcutaneously in the physician’s office. Now, there are 3 options available for at-home use: mepolizumab, benralizumab, and dupilumab.